PHOENIX, March 17, 2017 /Weed Wire/ — As of March 15, 2017, five participants have received marijuana (cannabis) provided by the National Institute on Drug Abuse (NIDA) in an ongoing Phase 2 clinical trial sponsored by the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS) at the Scottsdale Research Institute (SRI) in Phoenix, Ariz. MAPS is committed to sponsoring rigorous clinical research to develop cannabis into a prescription medicine through the Food and Drug Administration (FDA).
Tag Archives: MAPS
PTSD Marijuana Study Dispenses MMJ to First Military Veteran
On Feb. 6, 2017, the first clinical trial to study the effects of medical marijuana in the treatment of post-traumatic stress disorder in military veterans dispensed medical marijuana to its first veteran at the Scottsdale Research Institute in Phoenix.
First Participant Enrolled in First-Ever Trial of Marijuana for Chronic PTSD in Veterans
PHOENIX, Ariz., Feb. 7, 2017 /Weed Wire/ — On February 6, 2017, the first participant in the first-ever clinical trial of smoked marijuana (cannabis) for post-traumatic stress disorder (PTSD) in U.S. veterans received cannabis at the Scottsdale Research Institute (SRI) in Phoenix, Ariz.
The ‘Green Carpet’ is Ready to Roll in Las Vegas
As The World of Cannabis takes over Las Vegas next week, Marijuana Investor Summit will hold the Cannabis Industry Awards on the evening of Nov. 15, 2016, at the Rain Nightclub at the Palms Casino Resort.
Cannabis Industry Awards To Be Announced November 15, 2016
LAS VEGAS, Nov. 7, 2016 /Weed Wire/ — The Marijuana Investor Summit has announced that it will be holding the annual Cannabis Industry Awards on Tuesday, November 15 at The World of Cannabis conference in the Palms Casino Resort in Las Vegas, Nevada.
World of Cannabis: Bringing the Global Cannabis Community to the Palms Casino, Las Vegas, Nov. 15-16
LAS VEGAS, Oct. 25, 2016 /Weed Wire/ — Marijuana Investor Summit is bringing “The World of Cannabis” to the Palms Casino Resort in Las Vegas, Nevada, on Nov. 15-16.
Expert Updates, Networking and a ‘Green Carpet’ for Industry Stars
The legal cannabis industry is both global and local. On the one hand it must cope with obstacles and risks that are specific to a given municipality or even neighborhood. On the other it gets to participate in a worldwide phenomenon with constant opportunities defined by physiology and economics.
Colorado Awards $8.4M in MMJ Research Grants Amidst Controversy
GLENDALE, Colo. — The crowd of approximately 100 veterans, marijuana patients, doctors and activists erupted in cheers at about noon on December 17, 2014.
MMJ Research Recommendations for Colorado Board of Health
Thanks to the surplus of medical marijuana license registration fees in Colorado, the state can now use funds to finance new medical studies on marijuana.
Pink Ribbon Investing
October is Breast Cancer Awareness Month. We all know women and men who have suffered from this horrible disease. In 2014, approximately 300,000 new cases will be diagnosed and 40,000 women will die.
Leafly’s Strain Reviews for Mental Illnesses
As a marijuana resource site, Leafly allows users to review strains of marijuana; part of the review process allows users to select medical conditions and symptoms they believe a strain can treat, as well as allowing them to add their own medical conditions and symptoms they believe are treatable with specific strains.
PTSD Pot Study Seeks New Home in AZ
As was expected by the appealing parties, Dr. Susan Sisley’s appeal for reinstatement to the University of Arizona faculty was denied. The decision is final, and subject to no further review according to a letter dated July 28, 2014, from Dr. Andrew Comrie, the Senior Vice President for Academic Affairs and Provost for the University of Arizona.
Arizona Axes Medical Marijuana Doctor
The United States needs to focus on the problem of treating Post-Traumatic Stress Disorder, but the fight against PTSD suffered a setback when the University of Arizona fired Dr. Suzanne Sisley who had proposed studying the efficacy of cannabis as a PTSD treatment medication.